A germinal center–associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL

Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell malignancy, with varying prognosis after the gold standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Several prognostic models have been established by focusing primarily on characteristics of lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyawaki, Kohta, Kato, Koji, Sugio, Takeshi, Sasaki, Kensuke, Miyoshi, Hiroaki, Semba, Yuichiro, Kikushige, Yoshikane, Mori, Yasuo, Kunisaki, Yuya, Iwasaki, Hiromi, Miyamoto, Toshihiro, Kuo, Frank C., Aster, Jon C., Ohshima, Koichi, Maeda, Takahiro, Akashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006269/
https://www.ncbi.nlm.nih.gov/pubmed/34638128
http://dx.doi.org/10.1182/bloodadvances.2021004618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006269/
https://www.ncbi.nlm.nih.gov/pubmed/34638128
http://dx.doi.org/10.1182/bloodadvances.2021004618

Ejemplares similares